Recursion Pharmaceuticals, Inc. (RXRX) Presents at Jefferies London Healthcare Conference 2025 Transcript
Question-and-Answer SessionSo before we jump in, maybe just give some opening remarks in terms of some of the transition here, Najat. And just give us an update in terms of what's going on in terms of like the CEO and what kind of new thinking that you would be providing the company as CEO? And any kind of priorities for you over the next 12 to 18 months?Najat KhanChief R&D Officer, Chief Commercial Officer and Director Yes. No, first of all, thanks for having us. Great to be here. Yes. I mean, I think from ...